We have tested if inhaled nitric oxide (NO) is beneficial in ischaemia-repe
rfusion (IR) lung injury using an isolated perfused rabbit lung model. Isch
aemia for 60 min was followed by reperfusion and ventilation with nitric ox
ide 40 ppm (n=6) or without nitric oxide ventilation (n=6) for 60 min. In t
he control group (n=6), the lungs were perfused continuously for 120 min. P
ermeability coefficient (Kfc) and vascular resistance (PVR) were measured s
erially for 60 min after reperfusion. We also determined the left lung W/D
ratio and measured nitric oxide metabolites (NOx) and cGMP concentrations i
n bronchoalveolar lavage (BAL) fluid from the right lung. IR increased Kfc,
PVR and W/D followed by decreased cGMP. Ventilation with nitric oxide rest
ored these changes by preventing the decrease in cGMP. Differences in NOx c
oncentrations in BAL fluid between the control and IR groups were not stati
stically significant. Our results indicate that IR impaired pulmonary vascu
lar function and resulted in microvascular constriction and leakage. Ventil
ation with nitric oxide from the beginning of the reperfusion period improv
ed pulmonary dysfunction such as vasoconstriction and capillary leak by res
toring cGMP concentrations.